Katrina Hayter
Natalie Smith
Steve McLean
Steve became Head of Agriculture & Fisheries at M&S in March ’12, and has overall responsibility for agricultural and fisheries raw material supply chain and supply chain sustainability across the M&S Food business.
Steve initially joined M&S in September 2008 as Agriculture Manager responsible for ruminant livestock production and has worked extensively with the M&S supply base around the world on the industry leading M&S ‘Farming for the Future’ Sustainable Agricultural Programme.
Prior to joining M&S, Steve was Chief Executive of the Texel Sheep Society and Business Director of BASCO Data Limited, a collaboration between the UK’s three largest beef & sheep breed societies that managed performance and breed society data.
Steve’s family background has its roots firmly in the Scottish Fishing Industry, where his brother continues the tradition from the Scottish port of Gairloch on the North West coast.
Steve lives with his wife and 2 children in rural Oxfordshire where his wife is a partner in the family livestock farm.
Mark Shen
Mark Hirschhorn
Jason Tundermann
Jason is the Vice President of Business Development at LevelTen Energy. He primarily focuses on market expansion, strategic partnerships, product development, and PPA structuring. Prior to joining LevelTen, Jason spent 7.5 years at Lincoln Clean Energy, where his experience included origination (utility, C&I and financial/hedge), project development, M&A and strategy.
Phil Elkins
Mick Bailey
Mick graduated as a vet from Bristol in 1979, but has spent almost the whole of his career in research on mucosal immune responses. His interests are in the way the mucosal immune system responds to, and distinguishes between, harmless antigens from food and commensal micro-organisms and those from pathogens. His lab documented the way the mucosal immune system of the young pig develops in response to early microbial colonisation and has demonstrated the impact of early-life manipulation of microbiome with pre- and probiotics.
Leon Broom
Leon Broom is Chief Scientific Officer with Gut Health Consultancy, a leading company partnering with businesses to deliver their health and nutrition innovation strategies. Leon obtained both his BSc (Animal Science) and PhD (Nutrition and health interactions) from the University of Leeds, UK. He has since focussed on the intestine and its critical importance for health (including manipulation via nutrition and feed additives) through years' of experience in academic research or technical and research & development roles with global feed additive companies. Leon has published more than 40 articles, conference papers and peer-reviewed scientific journal papers, and recently established an annual Gut Health Symposium in the UK.
John Parkison
Dr John Parkinson is a computational biologist whose research interests focus on the impact of microbiota on human health. After completing his PhD at the University of Manchester, studying molecular self-assembly, John spent a year at the University of Manitoba investigating diatom morphogenesis. In 1997, John moved to Edinburgh where he applied computer models to study the evolution of complement control proteins with Dr Paul Barlow. With the emergence of high throughput sequencing, John then led the bioinformatics efforts associated with the parasitic nematode expressed sequence tag project, responsible for the processing and curation of sequence data from 30 species of parasitic nematodes. John was recruited to the Hospital for Sick Children in 2003 and was promoted to Senior Scientist in 2009. He holds cross-appointments in both the departments of Biochemistry and Molecular Genetics at the University of Toronto. Current lab interests center on the role of the microbiome in health and disease as well as the mechanisms that allow pathogens and parasites to survive and persist in their human hosts. Key to this research is the integration of computational systems biology analyses with comparative genomics to explore the evolution and operation of microbial pathways driving pathogenesis. Findings from our research programs are helping guide new strategies for therapeutic intervention.